Literature DB >> 11504167

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.

B Pitt, G Williams, W Remme, F Martinez, J Lopez-Sendon, F Zannad, J Neaton, B Roniker, S Hurley, D Burns, R Bittman, J Kleiman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11504167     DOI： 10.1023/a:1011119003788

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  64 in total

Review 1.  Aldosterone as a determinant of cardiovascular and renal dysfunction.

Authors:  M Epstein
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

Review 2.  Heart failure in women.

Authors:  J Julia Shin; Eman Hamad; Sandhya Murthy; Ileana L Piña
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

Review 3.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.

Authors:  Jennifer J DuPont; Iris Z Jaffe
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

Review 4.  Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure.

Authors:  S Ellery; L Williams; M Frenneaux
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 5.  Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.

Authors:  Clyde W Yancy
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 6.  Neprilysin inhibition: A brief review of past pharmacological strategies for heart failure treatment and future directions.

Authors:  Erik H Howell; Scott J Cameron
Journal:  Cardiol J       Date:  2016-09-26       Impact factor: 2.737

Review 7.  Aldosterone: a risk factor for vascular disease.

Authors:  Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis.

Authors:  P Ye; T Yamashita; D M Pollock; H Sasano; W E Rainey
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

Review 9.  Heart failure management: the present and the future.

Authors:  Mohammad N Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

10.  Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure.

Authors:  Joerg Honold; Ulrich Fischer-Rasokat; Florian H Seeger; David Leistner; Saskia Lotz; Stefanie Dimmeler; Andreas M Zeiher; Birgit Assmus
Journal:  Clin Res Cardiol       Date:  2013-04-24       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.